IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could enable physicians to detect diseases such as cancer before symptoms appear.
As reported today in the journal Nature Nanotechnology, the IBM team’s results show size-based separation of bioparticles down to 20 nanometers (nm) in diameter, a scale that gives access to important particles such as DNA, viruses and exosomes. Once separated, these particles can potentially be analyzed by physicians to reveal signs of disease even before patients experience any physical symptoms and when the outcome from treatment is most positive. Until now, the smallest bioparticle that could be separated by size with on-chip technologies was about 50 times or larger, for example, separation of circulating tumor cells from other biological components.
IBM is collaborating with a team from the Icahn School of Medicine at Mount Sinai to continue development of this lab-on-a-chip technology and plans to test it on prostate cancer, the most common cancer in men in the U.S.
In the era of precision medicine, exosomes are increasingly being viewed as useful biomarkers for the diagnosis and prognosis of malignant tumors. Exosomes are released in easily accessible bodily fluids such as blood, saliva or urine. They represent a precious biomedical tool as they can be used in the context of less invasive liquid biopsies to reveal the origin and nature of a cancer.
The IBM team targeted exosomes with their device as existing technologies face challenges for separating and purifying exosomes in liquid biopsies. Exosomes range in size from 20-140nm and contain information about the health of the originating cell that they are shed from. A determination of the size, surface proteins and nucleic acid cargo carried by exosomes can give essential information about the presence and state of developing cancer and other diseases.
exosomes of size 100 nm and larger could be separated from smaller exosomes, and that separation can take place in spite of diffusion, a hallmark of particle dynamics at these small scales. With Mt. Sinai, the team plans to confirm their device is able to pick up exosomes with cancer-specific biomarkers from patient liquid biopsies.
“The ability to sort and enrich biomarkers at the nanoscale in chip-based technologies opens the door to understanding diseases such as cancer as well as viruses like the flu or Zika,” said Gustavo Stolovitzky, Program Director of Translational Systems Biology and Nanobiotechnology at IBM Research. “Our lab-on-a-chip device could offer a simple, noninvasive and affordable option to potentially detect and monitor a disease even at its earliest stages, long before physical symptoms manifest. This extra amount of time allows physicians to make more informed decisions and when the prognosis for treatment options is most positive.”
Learn more:Â IBM Lab-on-a-Chip Breakthrough Aims to Help Physicians Detect Cancer
The Latest on: IBM Lab-on-a-Chip
[google_news title=”” keyword=”IBM Lab-on-a-Chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: IBM Lab-on-a-Chip
- AI chip startup DEEPX secures $80M Series C at a $529M valuationon May 9, 2024 at 4:00 pm
DEEPX is a South Korean on-device AI chip (NPU, or neural processing unit) startup that makes hardware and software for various AI applications in electronic devices. The company announced this week ...
- After two years, Doug Grose back as NY CREATES board chairon May 6, 2024 at 3:00 pm
Grose stepped down from position to support the America Semiconductor Innovation Coalition, a group poised to jump-start national chip lab perhaps in Albany.
- IBM to license Power chips to keep them relevanton April 23, 2024 at 1:42 am
PCWorld helps you navigate the PC ecosystem to find the products you want and the advice you need to get the job done.
- This tiny chip can safeguard user data while enabling efficient computing on a smartphoneon April 22, 2024 at 4:59 pm
To reduce this vulnerability, researchers from MIT and the MIT-IBM Watson AI Lab created a machine-learning accelerator that is resistant to the two most common types of attacks. Their chip can ...
- IBM Believes Its New 'Heron' Chip Is The First Step To Build A Quantum Computer More Powerful Than A Billion Connected Supercomputerson December 5, 2023 at 4:01 am
Tech giant IBM (NYSE:IBM) has introduced an innovative quantum computing chip, “Heron” as it looks beyond silicon chips to usher in a new era of computing and artificial intelligence.
- IBM sets Watson chips on the AI case as price war kicks offon July 13, 2023 at 2:12 am
IBM said it is considering the use of its own custom AI chips to lower the costs of operating its Watsonx services in the cloud. Watsonx, announced in May, is actually a suite of three products ...
- IBM PC Runs BASIC With Motorola 68000 CPU Upgradeon May 2, 2023 at 5:05 pm
[Ted Fried] has been experimenting with that scenario, by equipping an IBM PC with a 68000 CPU. To be fair, he didn’t use an actual Motorola chip; instead, he emulated a 68k core on a Teensy 4.1 ...
- IBM CEO Arvind Krishna: Chip Shortage ‘More Likely’ Continuing Until 2023 Or 2024on October 11, 2021 at 3:04 pm
While IBM no longer manufactures its own chips, the company does continue to ... research in semiconductors at the company’s lab in Albany, N.Y., Krishna said. In May, IBM announced it had ...
- IBM Reportedly Pays $1.3 Billion to GlobalFoundries to Take Failing Chip Uniton October 19, 2014 at 4:52 pm
IBM looks to be plugging a $1.5 billion drain on its earnings with a semiconductor unit sale to Abu Dhabi-owned GlobalFoundries. IBM looks to be plugging a $1.5 billion drain on its earnings with ...
- IBM Places Chips On Midmarket Partner Saleson March 7, 2008 at 9:18 am
That's the message Rich Michos, vice president of worldwide business partner strategy for IBM, delivered Thursday during the vendor's World Premier event at the XChange conference in Los Angeles.
via Bing News